What Is Adult Growth Hormone Deficiency in Women?

Adult Growth Hormone Deficiency (AGHD) is a medical condition in which the pituitary gland does not produce sufficient growth hormone. It is a distinct, diagnosable condition – separate from the natural changes in hormone levels that occur with aging or menopause.

Some women are diagnosed with AGHD during perimenopause or after menopause – but the timing is coincidental, not causal. Menopause is not a cause of AGHD, and HGH therapy is not a treatment for menopause. Women who experience menopausal symptoms should discuss estrogen and progesterone therapy with their provider. Women who have AGHD symptoms alongside menopausal symptoms may be evaluated for both conditions separately, with each treated through its appropriate clinical pathway.

AGHD in women typically occurs due to:

  • Pituitary disease, tumor, or structural abnormality
  • Prior pituitary surgery or radiation therapy
  • A documented history of childhood-onset growth hormone deficiency
  • Other conditions affecting pituitary or hypothalamic function

Diagnosis requires clinical evaluation and, in most cases, a growth hormone stimulation test interpreted alongside body mass index (BMI). A low GH reading alone is not sufficient for diagnosis – the full clinical picture must be evaluated by a licensed provider.

HGH is a federally controlled substance available only by prescription, and may only be legally prescribed for FDA-approved medical indications. Hormone Logics treats only patients who meet established clinical criteria for AGHD.

Symptoms That May Indicate AGHD in Women

Because some AGHD symptoms overlap with menopausal symptoms, AGHD can be overlooked in women. If you have a history of pituitary disease or prior pituitary-related treatment, the following symptoms may warrant evaluation for AGHD:

  • Persistent fatigue not explained by other causes
  • Reduced physical stamina and exercise capacity
  • Changes in body composition – increased fat mass, reduced lean muscle
  • Reduced bone density
  • Difficulty with memory or concentration
  • Low mood or reduced sense of wellbeing
  • Sleep disturbances
  • Reduced libido

These symptoms are non-specific and can be caused by many conditions, including menopause, thyroid disorders, and other hormonal changes. Lab testing and clinical evaluation are required to determine whether AGHD is contributing. Symptoms alone do not confirm a diagnosis.

Symptoms That May Indicate AGHD in Women

Note: "Increased risk of Alzheimer's disease" and "increased risk of heart disease" have been removed from this list. HGH therapy has not been approved or proven to prevent or treat Alzheimer's disease or cardiovascular disease.

Potential Benefits of HGH Therapy for Women with Diagnosed AGHD

In women with a confirmed AGHD diagnosis, FDA-approved HGH therapy may support:

  • Energy and physical capacity – Some patients with AGHD report improvements in energy levels and exercise tolerance. Results are not guaranteed and vary by individual.
  • Body composition – Women with AGHD may experience changes in lean body mass and fat distribution during treatment. These are not weight loss claims – individual results vary significantly.
  • Bone density – HGH therapy may support bone mineral density in patients with diagnosed AGHD, which is relevant for women at risk of osteoporosis.
  • Cognitive function – Some patients report improvements in memory and concentration. HGH is not approved to treat or prevent any cognitive disease.
  • Mood and quality of life – Studies in AGHD patients have noted improvements in quality of life measures. Results apply to diagnosed patients, not to general aging or menopause.
  • Sleep – Restorative sleep may improve in patients whose AGHD is appropriately treated.
  • Sexual health – Some women with AGHD report improvements in libido during treatment. Results vary.

Important: These potential benefits are associated with treatment of clinically diagnosed AGHD only. HGH therapy is not indicated for menopause, general wellness, anti-aging, or age-related hormone decline. Prescribing HGH for those purposes is not legal.

Risks and Side Effects

As with any prescription medication, HGH therapy carries risks that must be discussed with your provider before starting treatment. Potential side effects include:

  • Fluid retention (edema)
  • Joint and muscle pain
  • Carpal tunnel syndrome
  • Headaches
  • Increased insulin resistance or blood sugar changes
  • Injection site reactions

HGH therapy requires ongoing lab monitoring and regular follow-up with your prescribing provider. It is not appropriate for everyone. Patients with active malignancy, diabetic retinopathy, or certain other conditions may not be candidates. Your provider will review your complete medical history before recommending treatment.

Why Hormone Logics?

Hormone Logics is a licensed telehealth practice with experienced medical providers who specialize in hormone-related conditions. Our approach to AGHD in women includes:

  • Required comprehensive lab testing before any treatment recommendation
  • Diagnosis based on stimulation testing and established clinical criteria – not symptoms alone
  • Clear separation between AGHD treatment and menopausal hormone therapy – each addressed through its appropriate clinical pathway
  • Prescriptions issued only for FDA-approved indications
  • Ongoing monitoring throughout your treatment program
  • Compounding pharmacy partner: Strive Compounding Pharmacy, Tampa, FL

We do not prescribe HGH for menopause, anti-aging, general wellness, or performance purposes.

Call us at Call (800) 754-1481 to speak with an advisor about whether AGHD evaluation may be appropriate for you.

Common Questions About Growth Hormone Therapy

AGHD is a recognized medical condition in which the pituitary gland does not produce sufficient growth hormone. In women, it is caused by pituitary disease, injury, surgery, radiation, or in some cases is a continuation of childhood GHD. It is not the same as the natural changes in GH levels that occur with aging or menopause, and it requires a specific clinical diagnosis.
In adult women, HGH produced by the pituitary gland plays a role in regulating metabolism, body composition, bone density, and cell repair. In women with diagnosed AGHD, these functions may be impaired - producing symptoms such as fatigue, body composition changes, reduced bone density, and cognitive difficulties. These symptoms may overlap with menopausal symptoms, which is why proper diagnostic testing is important to identify the underlying cause.
Yes. HGH is a federally controlled substance and is only legally available with a physician's prescription for an FDA-approved medical indication. Any product claiming to contain HGH that is sold without a prescription is not real growth hormone. Legitimate HGH therapy is administered by injection only - oral supplements, pills, or sprays claiming to be HGH therapy are not.
AGHD is not cured, but it can be effectively managed with FDA-approved prescription HGH injections under medical supervision. Treatment is individualized and based on a confirmed diagnosis - not every woman with low energy or menopausal symptoms is a candidate for HGH therapy. If you have a history of pituitary disease or prior pituitary-related treatment, a formal evaluation by a Hormone Logics provider can determine whether AGHD is a contributing factor and whether treatment is appropriate for your situation.
Scroll to Top